Drug Approval | August 05, 2021
Combinations of Sputnik V component with other vaccines demonstrate favourable results: RDIF
AstraZeneca, Sinopharm and Moderna were part of the study
AstraZeneca, Sinopharm and Moderna were part of the study
Startup receives US $ 5 million in first round of funding
_logo_256_384.jpg){kind=logo}
It supports sequencing-based COVID 19 surveillance in India
Five seats reserved for Wards of COVID warriors in central MBBS admission
Apollo hospital-Hyderabad, Kainos Hospital-Rohtak and Apex Hospital Jaipur have deployed this solution
Aditya Puri former MD of HDFC bank joins Solara board as chairman
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
